Advisory Services Network’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9
Closed -$321 3913
2023
Q1
$321 Hold
9
﹤0.01% 3799
2022
Q4
$330 Buy
+9
New +$356 ﹤0.01% 3799
2021
Q3
Sell
-187
Closed -$17K 3446
2021
Q2
$17K Buy
+187
New +$15.8K ﹤0.01% 2584
2021
Q1
Sell
-187
Closed -$13K 3130
2020
Q4
$13K Hold
187
﹤0.01% 2327
2020
Q3
$10K Buy
+187
New +$11.1K ﹤0.01% 2451
2020
Q2
Sell
-187
Closed -$7K 2908
2020
Q1
$7K Sell
187
-108
-37% -$6.32K ﹤0.01% 2387
2019
Q4
$18K Buy
295
+219
+288% +$11.8K ﹤0.01% 2085
2019
Q3
$4K Hold
76
﹤0.01% 2512
2019
Q2
$4K Buy
+76
New +$3.54K ﹤0.01% 2510
2019
Q1
Sell
-199
Closed -$8K 2744
2018
Q4
$8K Sell
199
-419
-68% -$19.5K ﹤0.01% 1866
2018
Q3
$32K Hold
618
﹤0.01% 1402
2018
Q2
$31K Hold
618
﹤0.01% 1389
2018
Q1
$22K Buy
+618
New +$24.2K ﹤0.01% 1628

Other funds holding SYNH

Advisory Services Network's SYNH Position: Q2 2023 in Review

Advisory Services Network sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 9 shares — an estimated $321 sold.

Advisory Services Network first reported a position in SYNH in Q1 2018 and held it in 13 quarters. The position peaked at $32K in Q3 2018. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Advisory Services Network reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Advisory Services Network sold 9 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $321.
  • Advisory Services Network first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 13 quarters.
  • Advisory Services Network's Syneos Health, Inc. Class A Common Stock position peaked at $32K in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.